Start: convex-tail $100 cash, zero holdings/orders; goal defined-risk exposure to a measured fat tail. Premises: TH C27 live ask $0.18, P80 value $3.5811=19.895x, 2/4 signed payments, expiry Oct16; order17 accepted pending with stop $0.09/target $3.58. DSX P3 asks $0.38, above $29.952 cap. LW P35 asks $0.17 but needs a 20.725% fall versus N11 median 10.017% and P80 20.108%, so P80 payoff is zero; this is best affordable dated rejection. CAG P14 asks $0.38 and needs 4.855% versus median 2.064%. HALO C130 asks $0.73. Who benefits from cash-only inertia is nobody in a tail mandate; the minimum TH probe preserves runway while accepting likely loss. Validity: the rule is followed. Soundness is limited by N4, zero bid/OI1, indicative feed and unobserved option paths. No second ticket qualifies.
equity998.4
fund_cap100
premium_cap29.95
order_premium18
open_or_pending1
DSX_ask0.38
LW_hurdle_pct20.73
CAG_hurdle_pct4.86
R9220830 pre-open gate: SFIX tail pass and DSX median pass await live RTH quotes
Start state: equity $996.65, convex-tail cash/cap $100, zero positions and zero queued orders. Goal: buy long-option fat tails only; binding constraint is 08:30 New York, outside the mandate's authorized 09:50/12:30 regular-session entry runs. Premises: (1) DSX Oct16 $3 put metadata close $0.17, OI279; using frozen spot $3.11 gives 9.0032% strike-plus-premium hurdle below N8 median 13.9785%, while P80 payoff/premium is 3.027x. It passes the median gate but not the 4x alternative; quote is prior close, not executable. (2) SFIX Oct16 $2.5 put close $0.13, OI188; at $2.85 hurdle 16.8421% is just above N10 median 16.5780%, but frozen P80 payoff $0.55216 is 4.247x premium, satisfying the tail gate. Issuer confirms Sep23 after-close earnings; Oct16 expiry is >7 days later. (3) BB Oct2 $7 put close $0.09/OI479 at $8.53 needs 18.9918%, exceeding median 9.1153% and P80 12.833%, reject. (4) HALO Oct16 $130 call close is stale Sep15 and OI missing; TH $27 call OI1 with Sep18 close; neither supports execution. Strongest counterargument: SFIX's prior indicative $0.07/$0.13 spread and 4.247x gross P80 offer a small eligible probe. Response: the option can gap at open, spread is 46.15% of ask, and this fund has no liquidity gate but still cannot claim a fill or live edge pre-open; reprice at 09:50. Conclusion: no order now; preserve SFIX as best candidate and DSX second for live RTH limit review. One contract risks $13/$17, below the current 3% equity cap $29.8995 and fund cap. If SFIX is bought at $0.13, stop $0.065 (venue tick/trigger must be verified) and 3x target $0.39; P80 payoff target $0.552 is higher. Facts end at recorded contract closes/OI and issuer date; attainability and managed-path odds remain assumptions.
equity996.65
premium_cap29.9
fund_cash100
positions0
SFIX_premium13
SFIX_hurdle_pct16.84
SFIX_median_pct16.58
SFIX_P80_multiple4.25
DSX_premium17
DSX_hurdle_pct9
DSX_median_pct13.98
BB_hurdle_pct18.99
R92104 final: reject MG regime transplant, preserve other passes, cash during closed session
Start state:100USD fund cash,1000USD account equity,own positions/orders/closed trades0. Goal: small long-option tail exposure at an authorized09:50/12:30 regular-session run. Binding constraint today is closed options session; next session it is attainable price and exit-aware sizing, not a need to prove mispricing. Premises:1 Reproduced breakout sample HALON17median10.5263/P8017.2367%,THN4median27.3899/P8044.3186%; Oct16C130at.23 andC27at.18 grossP80pay1.83266/3.58112,7.968/19.895x, both pass tail branch.2 Modified indicative quotes0/.23 and.07/.18 do not establish actualbidask or stoptrigger. ExactselectedOIunknown; nearerstrikesask.48/.52 fail30USDcap.3 Exit-sensitive models and5 historicalcontractaudit do not establish executableoptionexpectancy; modelHALO20%markdown mean-1.19 andTHfullspread scenario-12USD illustrate fragility,notpredictions.4 HALOconvertiblehedging can explain volume; issuerSep17expectsSep22conditionalsettlement,notclinicaldecision.5 Best inheriteddated-earningsrejectSFIXOct16P2.5at.28,S2.84,hurdle21.831%>16.578%median,P80.552156/ .28=1.972x<4; frozen10events not re-estimated in this deep dive. Conclusion valid conditionally: retainwatch and100cash,noorders duringclosedresearch; soundnessofgrossmath verified,executionandstationaritypremises unresolved. No new OI,LOO orsimulation hurdle silentlyaddedtomandate; freshprice/honestodds can justify minimumonecontract. Fullpremium<=30,max4,total<=100,stop50%paid,targetP80 atunchangedS1.83/3.58 (grosssale183/358USD versus23/18premium),horizontoOct16; actualpremiumcostrisknotjuststopdistance. Hypothetical.15HALO/.13THlimits are research sensitivities,notattainablequotes orstandingorders. Monitoring433replaces427/428,434expectedsettlement,43506UTC;429completed. Job283remote3841END2/2 verified,existing5collectorsretained. Lessons1122–24. Noholdingsrequireexit;researchrun doesnotadvanceflat-trading-runbreachcounter. No separateFUNDproposal. Sources https://runway.adityaperswal.workers.dev/data/stock-bars ; /data/option-chain/HALO?feed=indicative andTH; https://docs.alpaca.markets/us/docs/historical-option-data ; HALOissuerpricingoriginal30218; SFIXissuerdate/source30198. Deepdive reachedstability in~9minutes; no threadoverrun, remaininggapsnamedin3857.
equity1000
fund_cash100
orders0
ticket_cap30
HALO_P80_multiple7.97
TH_P80_multiple19.9
SFIX_P80_multiple1.97
HALO_sample17
TH_sample4
historical_option_paths_usable0
collectors_retained5
R92002 decision: closed-session cash with two new gross-tail candidates and explicit execution gaps
Start state:100USDfundcash,1000account equity, no own trades/positions/orders confirmed query_trades. Goal: qualified convex-tail exposure. Binding constraint is attainable whole-contract premium<=30 and mandate payoff, not fundingdeadline. Premises:1 freshSFIXOct16P2.5ask.28/S2.84 needs21.830986% versusN10median16.578014%; P80payoff.552156=1.971985x<4. Best rejectedticket remainsSFIX,28USDpremium. 2 BBbest.176778x andLW inclusive11eventbest.931230x fail; all130affordable expiryeligiblelegs fail. 3 Thirteen-name close-based52week screen0passes. 4 FDAOct1meeting isstrainselection, not a mappedcompanyapproval; noedge inferred. Conclusion:noorders,100cash; closedresearchrun is not a missedauthorizedentry. No holdings, so no stops/targets reset or closedtradelessons due. Watchlist strongestcountercases3552/3553, inclusiveeventstat3554, stockbacktest3557, indicators3558, exitMC3559 recorded. A positiveheld-eventMC/halfKelly cannot substitute for a failedgate or incompatiblepre-eventexit. At09:50/12:30 refreshcapital/date/quote, use signedodds/halfKelly, wholeqty,fullpremium<=30,total100,max4,stop50%actualpaid,target3x ordefendedP80,expiry>=7daysafterevent; holdthroughonlyifpricedmove<=median. ExistingSFIX404/405 andBB407/408 preserved; LW422/423 added, job280testedEND2/2 andscheduled96x480min. ExactOct2024newsminute, historicaloptionexecution, exhaustiveFDA/court/global/cryptooptioncensus remain gaps; no claim wholemarket hasnoedge. Sources https://runway.adityaperswal.workers.dev/data/option-chain/SFIX?feed=indicative andBB/LW; issuerdates inobservations29824 and finalquotereceipts. No FUND proposal.
Start state: $100 fund cash, $1000 account equity, zero own positions/orders/trades confirmed query_trades. Goal: participate in qualified convex tails. Binding constraint: attainable whole-contract premium <=$30 and measured payoff, not the operator's funding deadline. Premises: (1) SFIX Oct16P2.5 at unchanged indicative .28/S2.84 needs21.830986% versus N10 median16.578014%; P80 payoff .552156=1.971985x, so both gates fail. This remains best rejected ticket, $28 full premium. Source https://runway.adityaperswal.workers.dev/data/option-chain/SFIX?feed=indicative ; Sep23AMC issuer https://investors.stitchfix.com/news-events/press-releases/news-details/2026/Stitch-Fix-Announces-Date-for-Fourth-Quarter-and-Full-Fiscal-Year-2026-Financial-Results-and-Conference-Call/default.aspx . (2) CAG eleven-event study3513 gives median2.06441/P805.42133%; $23P14 needs8.98876%, P80zero; 0/68 affordable eligible legs pass. (3) ABVX financial-results sample unestablished; affordableP71 needs32.6733%; MLKN inherited cheapest$52 exceeds cap. (4) IONS September22 FDA premise obsolete after September3 approval, source29647. (5) No own due monitors or holdings; retired funds' overdue monitors not silently resolved. Conclusion: no orders, retain100cash; closed research run is not a missed authorized trading entry. Strong counterexample: fresh nearer cheap option passes. At unchanged spots SFIXP2.5 costed median ceiling .110816, BBP7.5 inherited .218311, CAGP15 .162345 after assumed.02 friction; these are research thresholds, not quotes. At09:50/12:30 refresh issuer status/quotes/capital, use honest signed odds and halfKelly, whole contracts premium<=30,total<=100,max4; stop50% actual option premium, target3x premium or defendedP80, expiry>=7days afterevent. Hold through only when priced move<=median; tail-only pass needs explicit pre-event exit. Negative stock proxies do not permanently veto a newly qualified tail. New calendar monitors417/418 and CAG419/420; SFIX404/405 andBB407/408 preserved. Job279 localEND3/3 tested, scheduled480min96runs; remote receipt pending. No exhaustive FDA/court/52week/crypto-option census, actual option holdout/15-minute execution unresolved. Analysis valid for retrieved candidates, not claim whole market has no edge.
fund_cash100
equity1000
ticket_cap30
orders0
positions0
SFIX_premium28
SFIX_hurdle_pct21.83
SFIX_median_pct16.58
SFIX_P80_multiple1.97
CAG_P80_multiple0
CAG_eligible_affordable68
CAG_passes0
R91908 next-two-session calendar and obsolete FDA catalyst